Skip to content

Clinical trials

Phase 2 HIV Seropositivity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Seropositivity Phase: Phase 2 Country / region: United States Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20051
20061
20102
20141
20181
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AIM ImmunoTech Inc.2
National Institute of Allergy and Infectious Diseases (NIAID)2
AIDS Malignancy Consortium1
Columbia University1
Friends Research Institute, Inc.1
ImmunityBio, Inc.1
Johns Hopkins University1
National Cancer Institute (NCI)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Seropositivity10
HIV Infections6
Acquired Immunodeficiency Syndrome2
Burkitt Lymphoma1
Diarrhea1
Lymphoma, Large B-Cell, Diffuse1
Neoplasms1
Opioid-Related Disorders1
Plasmablastic Lymphoma1
Sarcoma1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.